{"id":"W3012736954","doi":"10.1007/s40257-020-00512-4","title":"Malignancy Rates in Brodalumab Clinical Studies for Psoriasis","year":2020,"lang":"en","type":"article","venue":"American Journal of Clinical Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":18,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Bausch Health; Ortho Dermatologics; Amgen","keywords":"Medicine; Ustekinumab; Psoriasis; Internal medicine; Ixekizumab; Psoriasis Area and Severity Index; Dermatology; Secukinumab; Psoriatic arthritis; Adalimumab","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001052003,0.0002552977,0.002519749,0.0001272103,0.00007233312,0.000007533278,0.0004213393,0.0002947806,0.0000615532],"category_scores_gemma":[0.004728958,0.0001954287,0.0008246223,0.0002949775,0.001065825,0.0001031982,0.00008158004,0.0005597057,0.000125685],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001723321,"about_ca_system_score_gemma":0.000287895,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000008704623,"about_ca_topic_score_gemma":0.00001605211,"domain_scores_codex":[0.9940817,0.001820182,0.003215618,0.000385785,0.00005521235,0.0004414946],"domain_scores_gemma":[0.9913955,0.00633189,0.001637888,0.0002026609,0.00030673,0.0001253271],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004811458,0.0007068432,0.5378715,0.00004488307,0.00276758,0.0003516184,0.0006648893,0.000004882192,0.0003095044,0.0006103577,0.01436273,0.4374938],"study_design_scores_gemma":[0.0631568,0.02571903,0.4917903,0.0004273403,0.002832581,0.003688443,0.01276625,0.00004422997,0.007462244,0.002940133,0.387648,0.001524669],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9749086,0.008413526,0.0002658858,0.01318431,0.002873182,0.000229263,0.0000234701,0.00002251293,0.00007920006],"genre_scores_gemma":[0.9895446,0.004866052,0.001901726,0.003174125,0.000413433,0.00001778005,0.00001130601,0.00002387686,0.00004708287],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4359691,"threshold_uncertainty_score":0.7969351,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1195996737246195,"score_gpt":0.4233082742569633,"score_spread":0.3037086005323438,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}